News Conference News TCT 2016 Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients Todd Neale November 02, 2016
Presentation TCT 2016 PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen November 01, 2016
News Opinion Conversations in Cardiology Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient? July 11, 2016
News Conference News TVT 2016 When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care Michael O'Riordan June 20, 2016
Presentation TVT 2016 New TAVR Risk Models (eg, From TVT and FRANCE 2 Registries): Development, Clinical Validation, Current Use, and Future Directions Presenter: David J. Cohen June 17, 2016
Presentation TVT 2016 Identifying the Futile AS Patient: When Are Extreme Comorbidities Too Much for TAVR? Presenter: David J. Cohen June 17, 2016
Presentation TVT 2016 The Reemergence of Transcarotid TAVR as a Worthwhile Alternative Presenter: David J. Cohen June 16, 2016
News Daily News Subanálisis del Ensayo CoreValve norteamericano: Solo la TAVR Femoral Ofrece una Ventaja en la Calidad de Vida Precoz sobre la Cirugía L.A. McKeown August 19, 2015
News Daily News CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery L.A. McKeown August 19, 2015
News Daily News Incluso con Más Experiencia la TAVR Transapical No ofrece una Mejor Calidad de Vida que la Cirugía Caitlin E. Cox June 15, 2015
News Daily News Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery Caitlin E. Cox June 15, 2015
News Daily News TAVR Mejora la Calidad de Vida asociada a la Salud en la Mayoría de Pacientes de Riesgo Extremo L.A. McKeown February 19, 2015
News Daily News TAVR Improves Health-Related QoL in Majority of Extreme-Risk Patients L.A. McKeown February 19, 2015
Presentation TCT 2014 CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke September 13, 2014
Presentation TCT 2014 US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds September 13, 2014
Presentation TCT 2014 PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia September 13, 2014